Navigation Links
Landauer, Inc. Reports Fiscal 2011 Second Quarter Results
Date:5/3/2011

11 was $13.8 million, an increase of 7 percent compared with $12.9 million for the six months ended March 31, 2010.  The resulting diluted earnings per share for the first half of fiscal 2011 were $1.47 compared with $1.38 for the same period in fiscal 2010.  Earnings before interest, taxes, depreciation and amortization ("EBITDA") were $24.4 million, a 6 percent increase compared with $23.0 million a year ago.  The increase is due primarily to the $1.4 million reduction in acquisition related transaction and reorganization costs for the first half of fiscal 2011.  A reconciliation of net income to EBITDA is included in the attached financial exhibits.

Radiation Monitoring SegmentRadiation Monitoring revenues for the first six months of fiscal 2011 declined 4 percent, or $2.0 million, to $51.4 million.  Of the decline, $2.1 million is due to the previously reported change in the supply relationship between Landauer and Nagase Landauer, the Company's unconsolidated joint venture in Japan.  Without the Nagase Landauer impact, domestic Radiation Monitoring revenues declined 4 percent, or $1.4 million, and international Radiation Monitoring revenues increased 11 percent, or $1.5 million, on organic growth in most regions and the strengthening of most foreign currencies against the dollar.

Radiation Monitoring gross margin for the six months ended March 31, 2011 increased to 70 percent from 67 percent in the year ago period, primarily due to the decline in lower margin sales to Nagase Landauer.  Selling, general and administrative costs for the first six months of fiscal 2011 increased 5 percent, or $0.8 million, to $15.1 million.  The increase is due primarily to costs to replace the Company's IT systems and increased spending to support international revenue growth.  Operating income, inclusive of the impact of acquisition related transaction and reorganization costs, for the six months ended March 31
'/>"/>

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Landauer, Inc. Appoints Two New Members to Board of Directors
2. Cynosure Reports Financial Results for the First Quarter of 2011
3. MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results
4. VIVUS Reports First Quarter 2011 Financial Results
5. Dendreon Reports First Quarter 2011 Financial Results
6. InterMune Reports First Quarter 2011 Financial Results and Business Highlights
7. Nektar Therapeutics Reports First Quarter 2011 Financial Results
8. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
9. China Green Material Technologies, Inc. Reports 2010 Financial Results
10. GeneLink Reports Denial of Appeal
11. GeneLink Reports 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 Mathematic studies at the Program ... and funded by the Jeffrey Epstein VI Foundation , ... be visually identified for elimination. These aggressive cells are the ... shows a topological map of what to look for when ... for while tumor cells can be extracted from biopsy, it,s ...
(Date:8/21/2014)... NJ (PRWEB) August 21, 2014 ... personal selling optimization technology and services for Life ... of “Grading Pharma’s Use of New Commercial Sales ... Measurement & Analytics. , The article examines some ... yield that are being tested in the pharmaceutical ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, the ... molecules, became available for purchase in Australia and New Zealand, ... RENU 28 works is, if you think about the definition ... of cellular renewal within your body. If you think about ... of cellular renewal. What RENU 28 does is it works ...
(Date:8/20/2014)... in measuring vibrational motion of a single molecule with ... of a single molecule differs from the behaviour of ... at the University of California, Irvine, where post-doctoral researcher ... a visiting fellow under professor Vartkess A. Apkarian, whose ... lead by Professor Eric O. Potma. The results of ...
Breaking Biology Technology:Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2RENU 28 Skin Care Now Available in Australia and New Zealand 2Seeing a molecule breathe 2
... Advances in biotechnology and life science research coupled with broader range ... culture market. Growth is likely to be fueled by heightened interest ... of industrial biopharmaceuticals. , ... San Jose, CA (PRWEB) ...
... today the,submission of the response to the FDA ... Single Dose Containers). In an,Approvable Letter received on ... respect to chemistry, manufacturing, and controls (CMC)., ... response as a Class 2,resubmission, under which the ...
... Calif., Nov. 5 Telik, Inc.,(Nasdaq: TELK ) ... per share, for,the third quarter ended September 30, 2008, ... per share, for the comparable period in 2007. The,$8.0 ... to,corporate and municipal notes investments with an auction reset ...
Cached Biology Technology:Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts 2Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts 3SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R) 2Telik Announces Financial Results for 2008 Third Quarter 2Telik Announces Financial Results for 2008 Third Quarter 3Telik Announces Financial Results for 2008 Third Quarter 4
(Date:8/20/2014)... Tennessee, Knoxville, research finds life can persist in a ... part of a team that examined waters and sediments ... sheet and found the extreme environment supports microbial ecosystems. ... Mikucki and her colleagues has implications for life in ... solar system. The findings are published in the current ...
(Date:8/20/2014)... -- Bay Area Lyme Foundation, which aims to make ... applauds new research published in an upcoming issue of ... Diseases . The findings show that ticks that ... the year, making the threat of Lyme disease year-round. ... of Public Health (CDPH) Vector-borne Disease Section and University ...
(Date:8/20/2014)... causes a burning spiciness that is irresistible to some, ... effect are using their findings to develop a new ... be caused by inflammation or other problems. They reported ... in clinical trials, in ACS, Journal of Medicinal ... decades ago, scientists had pegged a compound called capsaicin ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3
... pollination season approaches in Pennsylvania and the Northeast, scientists ... to the decline of the nation,s honeybees and other ... billion worth of crops in the United States. To ... has stepped up to support honeybee research and education. ...
... X-rays have been used for decades to take ... Department of Energys (DOE) Argonne National Laboratory and their ... take images of ultra-small structures buried in nanoparticles and ... cellular nuclei. Argonne scientists along with scientists from ...
... puzzle found in rocks half a billion years old. ... world are the Burgess Shales in the Canadian Rockies. Once ... suddenly became more complex and diverse the so-called Cambrian ... Normally, only hard parts of ancient animals became fossilised; the ...
Cached Biology News:Haagen-Dazs gift to support Penn State honeybee research 2Haagen-Dazs gift to support Penn State honeybee research 3Lensless camera uses X-rays to view nanoscale materials and biological specimens 2Lensless camera uses X-rays to view nanoscale materials and biological specimens 3
... anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... dependent dilution. ICC: Use at an assay dependent ... - 10 ug/ml, this concentration is determined using ... weight: 40 kDa. Not tested in other applications. ...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Anti human PPAR gamma2 mouse monoclonal antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: